CARISMA THERAPEUTICS INC (CARM)
US14216R1014 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to CARM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.01. This target is 548.2% above the current price.
CARM was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CARM.
In the previous month the buy percentage consensus was at a similar level.
CARM was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-11 | BTIG | Initiate | Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-03 | Capital One | Initiate | Overweight |
| 2023-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-06 | Evercore ISI Group | Initiate | Outperform |
| 2023-06-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-28 | Baird | Reiterate | Outperform -> Outperform |
| 2023-05-24 | HC Wainwright & Co. | Initiate | Buy |
| 2023-04-14 | Baird | Initiate | Outperform |